Todd C. Davis - Dec 4, 2025 Form 4 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Role
Chief Executive Officer, Director
Signature
By: /s/ Andrew Reardon, Attorney-in-Fact For: Todd C. Davis
Stock symbol
LGND
Transactions as of
Dec 4, 2025
Transactions value $
$0
Form type
4
Date filed
12/8/2025, 07:37 PM
Previous filing
Jul 7, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Davis Todd C Chief Executive Officer, Director 555 HERITAGE DRIVE, SUITE 200, JUPITER By: /s/ Andrew Reardon, Attorney-in-Fact For: Todd C. Davis 2025-12-08 0001392029

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LGND Common Stock Gift $0 -130 -0.08% $0.00 161K Dec 4, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a bona fide gift of shares to a charitable entity.